SHORT MINI-FUTURE - AMGEN | Delayed Deutsche Boerse AG 01:45:16 26/06/2024 pm IST | ||
| 3.57 EUR | +0.85% |
|
| Current month | -26.56% | ||
| 1 month | -23.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 3.57 | +0.85% |
| 25/24/25 | 3.54 | -10.15% |
| 24/24/24 | 3.94 | -10.66% |
| 21/24/21 | 4.41 | -2.65% |
| 20/24/20 | 4.53 | -3.00% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 01:45 pm IST
More quotesStatic data
| Product type | Warrant Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VU1MCA |
| ISIN | DE000VU1MCA7 |
| Date issued | 04/01/2023 |
| Strike | 357 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.78 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.57 € |
|---|---|
| Lowest since issue | 3.04 € |
| Spread | 0.12 € |
| Spread % | 3.23% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Certificat
